Asymptomatic Crohn’s disease identified in a patient being treated with secukinumab: A case report:

IL-17 antagonism is among the most potent treatments for psoriasis. Generally safe, new onset and exacerbations of inflammatory bowel disease may occur in association with IL-17 therapy. We describ...